TRAVERE THERAPEUTICS, INC. (TVTX) Operating margin 2016–2025
TRAVERE THERAPEUTICS, INC. (TVTX) operating margin by fiscal year — reported operating income divided by reported revenue.
-12.8%FY2025 · since FY2016: -43.6% → -12.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -12.8% | +126.1 pp |
| FY2024 | -138.9% | +128.4 pp |
| FY2023 | -267.2% | +24.9 pp |
| FY2022 | -292.2% | -140.9 pp |
| FY2021 | -151.3% | -62.4 pp |
| FY2020 | -88.8% | -10.5 pp |
| FY2019 | -78.3% | -29.6 pp |
| FY2018 | -48.7% | -14.0 pp |
| FY2017 | -34.7% | +8.9 pp |
| FY2016 | -43.6% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice